The new wave of p75 neurotrophin receptor targeted therapies
- PMID: 34100437
- PMCID: PMC8451542
- DOI: 10.4103/1673-5374.314304
The new wave of p75 neurotrophin receptor targeted therapies
Conflict of interest statement
None
References
-
- Balea M, Birle C, Costin C, Marton J, Muresanu IA, Jemna N, Popa LL, Slavoaca D, Rosu OV, Stan A, Vacaras V, Strilciuc S, Muresanu DF. Effects of N-Pep-12 dietary supplementation on neurorecovery after ischemic stroke. Neurol Sci. 2020 doi: 101007/s10072-020-04707-9. - PubMed
-
- Gavrilova SI, Alvarez A. Cerebrolysin in the therapy of mild cognitive impairment and dementia due to Alzheimer’s disease: 30 years of clinical use. Med Res Rev. 2020 doi: 101002/med21722. - PubMed
-
- Heneka MT, Golenbock DT, Latz E. Innate immunity in Alzheimer’s disease. Nat Immunol. 2015;16:229–236. - PubMed
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources